Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.12 +0.05 (+1.60%)
As of: Oct 21, 2026 · 3:44 PM EDT

Galmed Pharmaceuticals (EOCN) Interest Coverage Ratio (2022 - 2023)

Updated

Galmed Pharmaceuticals' Interest Coverage Ratio was 2201.00 in FY2024, up 76.3% from 1248.67 in FY2023.

Analysis

Galmed Pharmaceuticals (EOCN) Interest Coverage Ratio (2022 - 2023) Analysis & Trends

From FY2011 onward, Galmed Pharmaceuticals has reported Interest Coverage Ratio for 13 years.

  • The FY2024 figure marks the highest annual Interest Coverage Ratio since FY2021.
  • Per Business Quant data, Interest Coverage Ratio in earlier years was 1248.67 in FY2023 (+154.7%), 490.31 in FY2022 (-91.1%), 5480.17 in FY2021 and 201.40 in FY2020 (+29.6%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.41
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 10.28
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 7.27
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 5.22
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -42.08
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Galmed Pharmaceuticals 1.68 Mn -39.01 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -3.42
Mar 31, 2022 -4.90
API Access

Galmed Pharmaceuticals Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=EOCN&period=max&api_key=YOUR_API_KEY